2104 Derived neutrophil to lymphocyte ratio is not predictive for use of a continuous or intermittent first-line oxaliplatin/fluoropyrimidine combination in patients with advanced colorectal cancer: A post-hoc analysis of the MRC COIN study

First Line ◽

Post Hoc Analysis ◽

Lymphocyte Ratio ◽

2105 Derived neutrophil to lymphocyte ratio as prognostic factor in patients with advanced colorectal cancer according RAS and BRAF mutations status: A post-hoc analysis of the MRC COIN study

European Journal of Cancer ◽

10.1016/s0959-8049(16)31027-9 ◽

2015 ◽

Vol 51 ◽

pp. S364

Author(s):

T. Grenader ◽

S. Nash ◽

R. Adams ◽

R. Kaplan ◽

D. Fisher ◽

...

Keyword(s):

Colorectal Cancer ◽

Prognostic Factor ◽

Braf Mutations ◽

Post Hoc Analysis ◽

Lymphocyte Ratio ◽

Revealing potential immune responses (IRs) in patients with advanced colorectal cancer (aCRC) on first line chemotherapy: A prospective study of neutrophil to lymphocyte ratio, immune function and outcome

Annals of Oncology ◽

10.1093/annonc/mdx390.029 ◽

2017 ◽

Vol 28 ◽

pp. v582

Author(s):

S. Turnbull ◽

E. West ◽

K. Scott ◽

E. Tidswell ◽

A. Melcher ◽

...

Keyword(s):

Colorectal Cancer ◽

Immune Responses ◽

Prospective Study ◽

Immune Function ◽

First Line ◽

Lymphocyte Ratio ◽

A Prospective Study ◽

Line Chemotherapy

The prognostic impact of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio in patients with advanced colorectal cancer treated with first-line chemotherapy

Gastroenterology Review ◽

10.5114/pg.2018.78287 ◽

2018 ◽

Vol 13 (3) ◽

pp. 218-222

Author(s):

Magdalena Krakowska ◽

Sylwia Dębska-Szmich ◽

Rafał Czyżykowski ◽

Anna Zadrożna-Nowak ◽

Piotr Potemski

Keyword(s):

Colorectal Cancer ◽

Prognostic Impact ◽

First Line ◽

Platelet To Lymphocyte Ratio ◽

Lymphocyte Ratio ◽

Lymphocyte To Monocyte Ratio ◽

Line Chemotherapy

Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study

British Journal of Cancer ◽

10.1038/bjc.2016.23 ◽

2016 ◽

Vol 114 (6) ◽

pp. 612-615 ◽

Cited By ~ 22

Author(s):

Tal Grenader ◽

Stephen Nash ◽

Richard Adams ◽

Richard Kaplan ◽

David Fisher ◽

...

Keyword(s):

Colorectal Cancer ◽

Intermittent Therapy ◽

Neutrophil Lymphocyte Ratio ◽

Post Hoc Analysis ◽

Lymphocyte Ratio ◽

Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study

Cancer Management and Research ◽

10.2147/cmar.s198651 ◽

2019 ◽

Vol Volume 11 ◽

pp. 4357-4369 ◽

Cited By ~ 2

Author(s):

Andrea Casadei-Gardini ◽

Emanuela Scarpi ◽

Paola Ulivi ◽

Maria Angela Palladino ◽

Caterina Accettura ◽

...

Keyword(s):

Colorectal Cancer ◽

Lactate Dehydrogenase ◽

Prognostic Role ◽

Lymphocyte Ratio ◽

Inflammatory Index

Derived neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer according to RAS and BRAF status

Anti-Cancer Drugs ◽

10.1097/cad.0000000000000488 ◽

2017 ◽

Vol 28 (5) ◽

pp. 546-550 ◽

Cited By ~ 6

Author(s):

Georgina Wood ◽

Tal Grenader ◽

Stephen Nash ◽

Richard Adams ◽

Richard Kaplan ◽

...

Keyword(s):

Colorectal Cancer ◽

Prognostic Factor ◽

Lymphocyte Ratio

Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study

Supportive Care in Cancer ◽

10.1007/s00520-020-05972-2 ◽

2021 ◽

Author(s):

Alessandra Raimondi ◽

Salvatore Corallo ◽

Sara Lonardi ◽

Carlotta Antoniotti ◽

Lorenza Rimassa ◽

...

Keyword(s):

Colorectal Cancer ◽

Skin Toxicity ◽

First Line ◽

Post Hoc Analysis ◽

Early Tumor Shrinkage (ETS) For the Prediction of Efficacy in Metastatic Colorectal Cancer (MCRC): Post-Hoc Analysis from an Irinotecan-Based Randomized First-Line Trial

Annals of Oncology ◽

10.1016/s0923-7534(20)33213-0 ◽

2012 ◽

Vol 23 ◽

pp. ix204

Author(s):

C. Giessen ◽

R. Laubender ◽

S. Stintzing ◽

L. Fischer von Weikersthal ◽

D. Quietzsch ◽

...

Keyword(s):

Colorectal Cancer ◽

Tumor Shrinkage ◽

First Line ◽

Post Hoc Analysis ◽

Early Tumor Shrinkage ◽

Early Tumor ◽

Aflibercept/Folfiri vs Placebo/Folfiri in Metastatic Colorectal Cancer: A Post-Hoc Analysis of Median Overall Survival in Velour from the Retrospectively Assessed Time of Starting First-Line Treatment

Annals of Oncology ◽

10.1093/annonc/mdu165.282 ◽

2014 ◽

Vol 25 ◽

pp. ii104 ◽

Cited By ~ 1

Author(s):

Tabernero Josep ◽

Macarulla Teresa ◽

Humblet Yves ◽

ten Tije Albert ◽

Kroening Hendrik ◽

...

Keyword(s):

Colorectal Cancer ◽

Overall Survival ◽

Median Overall Survival ◽

Line Treatment ◽

First Line ◽

Post Hoc Analysis ◽

Post Hoc ◽

First Line Treatment

Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials

BMC Cancer ◽

10.1186/s12885-019-5319-8 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 18

Author(s):

Nicolas Charette ◽

Caroline Vandeputte ◽

Lieveke Ameye ◽

Camille Van Bogaert ◽

Jonathan Krygier ◽

...

Keyword(s):

Colorectal Cancer ◽

Adipose Tissue ◽

Muscle Mass ◽

Phase Ii ◽

Prognostic Value ◽

Phase Ii Trials ◽

Post Hoc Analysis ◽

Randomized Phase Ii ◽